The FDA's warning letters notified the companies they may be subject to legal action if they do not stop manufacturing and distributing "prescription unapproved products" that include high-concentrate morphine sulfate oral solutions and immediate-release tablets containing morphine sulfate, hydromorphone or oxycodone.

CNN: FDA warns makers of unapproved narcotics

Piaguaje had flown to New York to attend an oral argument before the Second Circuit Court of Appeals, centering on whether Judge Kaplan had the authority to stop the plaintiffs from collecting on the Ecuadoran judgment anywhere in the world.

NEWYORKER: Reversal of Fortune